These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Treatment with valproate and hepatic steatosis]. Ortiz-Sáenz de Santa María R; Santiago-Fernández C; Cano-Del Pozo M; Pérez-Gil O; Soto-Alvarez MI; Barriuso-Pérez E; Moche-Loeri JA Rev Neurol; 2005 Dec 16-31; 41(12):766-7. PubMed ID: 16355364 [No Abstract] [Full Text] [Related]
27. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy. Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255 [No Abstract] [Full Text] [Related]
28. Reversible effects of antiepileptic drugs on thyroid hormones in men and women with epilepsy: a prospective randomized double-blind withdrawal study. Lossius MI; Taubøll E; Mowinckel P; Gjerstad L Epilepsy Behav; 2009 Sep; 16(1):64-8. PubMed ID: 19646931 [TBL] [Abstract][Full Text] [Related]
29. [Effectiveness and tolerance of valproic acid monotherapy in patients with epilepsy]. Fröscher W; Frohn C Nervenarzt; 1988 May; 59(5):286-95. PubMed ID: 3136402 [No Abstract] [Full Text] [Related]
30. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Ristić AJ; Vojvodić N; Janković S; Sindelić A; Sokić D Epilepsia; 2006 Dec; 47(12):2183-5. PubMed ID: 17201721 [TBL] [Abstract][Full Text] [Related]
31. Hepatic functions in epileptics on sodium valproate monotherapy. Jha S; Agarwal DK; Shukla S; Nag D; Saxena RC Indian J Physiol Pharmacol; 1995 Jul; 39(3):305-6. PubMed ID: 8550134 [No Abstract] [Full Text] [Related]
32. Fractures and Fanconi syndrome due to prolonged sodium valproate use. Dhillon N; Högler W Neuropediatrics; 2011 Jun; 42(3):119-21. PubMed ID: 21717384 [TBL] [Abstract][Full Text] [Related]
33. [Embryopathy due to valproic acid with severe malformations in the central nervous system]. Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769 [TBL] [Abstract][Full Text] [Related]
34. [Three cases of Fanconi syndrome associated with valproate sodium treatment]. Inoue T; Tanaka Y; Otani R; Itabashi H; Murakami N; Nagai T; Sakuta R No To Hattatsu; 2011 May; 43(3):233-7. PubMed ID: 21638910 [TBL] [Abstract][Full Text] [Related]
35. [Valproate sustained release in the treatment of epilepsy]. Stefan H; Fraunberger B Fortschr Neurol Psychiatr; 2005 Nov; 73(11):681-6. PubMed ID: 16283612 [TBL] [Abstract][Full Text] [Related]
36. Valproate-induced Parkinsonism in epilepsy patients. Jamora D; Lim SH; Pan A; Tan L; Tan EK Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396 [TBL] [Abstract][Full Text] [Related]
37. [Parkinsonism induced by sodium valproate]. del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795 [TBL] [Abstract][Full Text] [Related]
38. More on valproate and polycystic ovaries. Johnston HF J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):354. PubMed ID: 10199101 [No Abstract] [Full Text] [Related]
39. Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy. Attilakos A; Voudris KA; Katsarou E; Prassouli A; Mastroyianni S; Garoufi A Clin Neuropharmacol; 2007; 30(3):145-9. PubMed ID: 17545749 [TBL] [Abstract][Full Text] [Related]